The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali & PACs

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.5%1-day move

₹120.60

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-0.5-2.5-2.5-0.7+1.2+3.0+6.9-21.3——

Up moveDown movePending

AI summary

Promoter Jay Arvind Bhanushali, along with five Persons Acting in Concert (PACs), acquired 22,82,507 equity shares (22.18%) of Aspira Pathlab & Diagnostics Ltd through an open offer on 08-06-2026. Jay Arvind Bhanushali individually picked up 5,11,738 shares (4.97%), while the largest acquirer among PACs was Arvind Karsandas Bhanushali who bought 5,33,914 shares (5.19%). The combined promoter group holding rose substantially from 23.82% to 46.00% post-acquisition, almost doubling control. The company's total equity capital remained unchanged at 1,02,93,000 shares of Rs. 10 each.

Likely market impact

This is a major promoter consolidation move via open offer, nearly doubling promoter stake to 46% — a strong sign of promoter confidence and tighter control, though minority shareholders should note reduced public float potential.